|[February 07, 2014]
Research and Markets: Trypanosomiasis - Pipeline Review, H2 2013 Research Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/z239dh/trypanosomiasis)
has announced the addition of the "Trypanosomiasis
- Pipeline Review, H2 2013" report to their offering.
'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of
the indication's therapeutic pipeline. This report provides information
on the therapeutic development for Trypanosomiasis, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
- A snapshot of the global therapeutic scenario for Trypanosomiasis.
- A review of the Trypanosomiasis products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Trypanosomiasis pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Pipeline Products for Trypanosomiasis - Overview
Pipeline Products for Trypanosomiasis - Comparative Analysis
Trypanosomiasis - Therapeutics under Development by Companies
Trypanosomiasis - Therapeutics under Investigation by
Trypanosomiasis - Pipeline Products Glance
Early Stage Products
Trypanosomiasis - Products under Development by Companies
Trypanosomiasis - Products under Investigation by Universities/Institutes
Trypanosomiasis - Companies Involved in Therapeutics Development
Trypanosomiasis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target (News - Alert)
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
Subunit Vaccine For Trypanosomiasis - Drug Profile
Xenomycin - Drug Profile
Cysteine Proteases Inhibitors - Drug Profile
Drug For Parasitic Diseases - Drug Profile
Nitrobenzyl Phosphoramide Mustards - Drug Profile
Trypanosomiasis - Recent Pipeline Updates
Panacela Labs, Inc.
For more information visit http://www.researchandmarkets.com/research/z239dh/trypanosomiasis
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]